Flotetuzumab
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Flotetuzumab, covering 2023-12-11 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies [Phase 1]